Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
批准号:
10227272
负责人:
HUAFENG WEI
金额:
$33.28万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2023-12-31
关键词:
2019-nCoVACE2AddressAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease patientApoptosisBindingCOVID-19COVID-19 patientCOVID-19 treatmentCalcineurinCathepsin LCathepsinsCell DeathCell NucleusCell membraneCellsCessation of lifeClinicalClinical ResearchCytosolDantroleneDataDoseEndocytosisEndoplasmic ReticulumEndosomesEpithelialExposure toFibroblastsFunctional disorderFutureGenetic TranscriptionGoalsGrantHomeostasisHumanImpairmentInfectionKidneyKnock-inLysosomesMediatingMembraneMitochondriaModelingMutationNeuronsNuclear Pore ComplexOxygenOxygen ConsumptionParentsPathologicPathway interactionsPatientsPharmaceutical PreparationsPharmacotherapyPlayProcessProductionProteinsRNA replicationReactive Oxygen SpeciesReportingRisk FactorsRoleRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSARS-CoV-2 infectionSARS-CoV-2 inhibitorSARS-CoV-2 spike proteinSkinStressTestingToxic effectTransfectionVirusVirus DiseasesVirus Replicationagedcell injurycytokinecytokine release syndromedrug repurposingefficacy evaluationendoplasmic reticulum stressexperimental studyinduced pluripotent stem cellinhibitor/antagonistneuroblastoma cellneurogenesisneuroprotectionnuclear factors of activated T-cellspandemic diseasepresenilin-1preventreceptorsensorside effectstem cellssynaptogenesistranslational studyviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Coronavirus disease 2019 (COVID-19), a pandemic affecting millions of patients around
the world, is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with no
effective drug treatments. Both infection and transfection of virus in host cells require
abnormally elevated Ca2+ concentrations in cytosol and endosome via overactivation of
ryanodine receptors (RyRs) Ca2+ channel located on the membrane of the endoplasmic
reticulum (ER). Dantrolene, an antagonist of RyRs, has been demonstrated to inhibit SARS-
CoV-2-mediated host cell toxicity and damage. In the presence of RyRs overactivation and
excessive and abnormal elevation of cytosolic and endosome Ca2+ concentrations, the spike
proteins (S1, S2) of the virus play important roles in binding, fusion, and virus replication in the
host cell, eventually leading to cell damage or death. Our long-term goal is to examine the
efficacy and mechanisms of dantrolene to treat AD. The overall objective of this study is to
investigate the effects and underlying mechanisms of dantrolene to protect against host cell
damage or death induced by SARS-CoV-2 spike proteins-mediated overactivation of RyRs and
associated Ca2+ dysregulation. Our central hypothesis supported by preliminary data is that
dantrolene inhibits SARS-CoV-2 spike proteins-mediated cell damage by inhibiting the
overactivation of RyRs and by restoring intracellular Ca2+ homeostasis in AD cells. We
will test this hypothesis with the following specific aims. Specific Aim 1 (SA1). To determine
the effects of dantrolene on SARS-CoV-2 spike (S) proteins-mediated Ca2+ dysregulation
and cell damage by apoptosis in AD cells using induced pluripotent stem cells (iPSC), from
skin fibroblasts of patients with either sporadic (SAD) or familial (FAD), and human
neuroblastoma cells (SH-SY5Y), with knocked-in AD presenilin 1 mutation (M146L). Specific
Aim 2 (SA2). To determine the effects and mechanisms of dantrolene on SARS-CoV-2
spike (S) proteins-mediated pathological pathways leading to host cell damage. We will
examine the effects of S proteins on mitochondria oxygen consumption, ATP production,
reactive oxygen species (ROS) production, ER stress, and cytokine release. We will correlate
the results between SA1 and SA2. We expect that dantrolene will inhibit S proteins-mediated
overactivation of RyRs and associated disruption of intracellular Ca2+ homeostasis and cell
death by apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
-
批准号:10343664
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
-
批准号:10570995
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2019
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7929736
-
项目类别:
-
资助金额:$14.78万
-
财政年份:2009
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of Anesthesia Mediated Neurotoxicity
-
批准号:9022481
-
项目类别:
-
资助金额:$32.35万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7690355
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:8306165
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7504657
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:8113131
-
项目类别:
-
资助金额:$27.18万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:8264392
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
-
批准号:7893633
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2008
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7057847
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:6859612
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7596179
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7386006
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
Volatile anesthetics, calcium homeostasis and apoptosis
-
批准号:7215168
-
项目类别:
-
资助金额:$12.79万
-
财政年份:2005
-
负责人:HUAFENG WEI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
-
批准号:JCZRLH202600625
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
-
批准号:2026JJ50619
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:翁春艳
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介
导“肠-胰岛 ”轴血糖调控功能的降糖机制研
究
-
批准号:Y24H280055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:颜美秋
-
依托单位:
人类ACE2变构抑制剂的成药性及其抗广谱冠状病毒感染的机制研究
-
批准号:82330111
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:刘刚
-
依托单位:
CAFs来源的外泌体负性调控ACE2促进肾透明细胞癌癌栓新辅助靶向耐药的机制研究
-
批准号:82373169
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:顾良友
-
依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2受体识别及细胞入侵机制研究
-
批准号:32300137
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈静
-
依托单位:
基于外泌体miRNAs介导细胞通讯的大豆ACE2激活肽调控血管稳态机制研究
-
批准号:32302080
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:宋田源
-
依托单位:
基于AT2/ACE2/Ang(1-7)/MAS轴调控心脏-血管-血液系统性重构演变规律研究心衰气虚血瘀证及其益气通脉活血化瘀治法生物学基础
-
批准号:82305216
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:姚骏凯
-
依托单位:
感毒清经ACE2/Ang(1-7)/MasR信号通路抑制PM2.5诱导慢性气道炎症的机制:聚焦肺泡巨噬细胞极化与“胞葬”的表型串扰
-
批准号:82305171
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴永灿
-
依托单位: